CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 161 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,567,093 | +45.0% | 93,281 | +78.8% | 0.00% | 0.0% |
| Q2 2023 | $1,770,467 | +17.4% | 52,180 | +24.5% | 0.00% | 0.0% |
| Q1 2023 | $1,507,562 | -19.3% | 41,900 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,867,483 | +58.5% | 41,900 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,178,000 | +4.2% | 41,900 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,130,000 | -19.1% | 41,900 | +2.2% | 0.00% | 0.0% |
| Q1 2022 | $1,396,000 | -11.6% | 41,000 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $1,580,000 | -28.4% | 40,900 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,208,000 | +61.4% | 40,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,368,000 | – | 40,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|